Uno N - Search Results

1

Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody.

Johnson NV, Wall SC, Kramer KJ, Holt CM, Periasamy S, Richardson S, Suryadevara N, Andreano E, Paciello I, Pierleoni G, Piccini G, Huang Y, Ge P, Allen JD, Uno N, Shiakolas AR, Pilewski KA, Nargi RS, Sutton RE, Abu-Shmais AA, Parks R, Haynes BF, Carnahan RH, Crowe JE Jr, Montomoli E, Rappuoli R, Bukreyev A, Ross TM, Sautto GA, McLellan JS, Georgiev IS. Johnson NV, et al. Among authors: uno n. bioRxiv [Preprint]. 2024 Jan 16:2024.01.15.575741. doi: 10.1101/2024.01.15.575741. bioRxiv. 2024. PMID: 38293237 Free PMC article. Preprint.

2

Putting the pieces together: Chimeric virus strategy decode Dengue virus 3 antibody responses.

Uno N, Ross TM. Uno N, et al. Cell Host Microbe. 2023 Nov 8;31(11):1772-1773. doi: 10.1016/j.chom.2023.10.014. Cell Host Microbe. 2023. PMID: 37944489

3

Multivalent next generation influenza virus vaccines protect against seasonal and pre-pandemic viruses.

Uno N, Ross TM. Uno N, et al. Sci Rep. 2024 Jan 16;14(1):1440. doi: 10.1038/s41598-023-51024-0. Sci Rep. 2024. PMID: 38228649 Free PMC article.

4

Universal Dengue Vaccine Elicits Neutralizing Antibodies against Strains from All Four Dengue Virus Serotypes.

Uno N, Ross TM. Uno N, et al. J Virol. 2021 Jan 28;95(4):e00658-20. doi: 10.1128/JVI.00658-20. Print 2021 Jan 28. J Virol. 2021. PMID: 33208445 Free PMC article.

5

Dengue virus and the host innate immune response.

Uno N, Ross TM. Uno N, et al. Emerg Microbes Infect. 2018 Oct 10;7(1):167. doi: 10.1038/s41426-018-0168-0. Emerg Microbes Infect. 2018. PMID: 30301880 Free PMC article. Review.

6

Formulation of dry powders of vaccines containing MF59 or AddaVax by Thin-Film Freeze-Drying: Towards a dry powder universal flu vaccine.

AboulFotouh K, Uno N, Xu H, Moon C, Sahakijpijarn S, Christensen DJ, Davenport GJ, Cano C, Ross TM, Williams Iii RO, Cui Z. AboulFotouh K, et al. Among authors: uno n. Int J Pharm. 2022 Aug 25;624:122021. doi: 10.1016/j.ijpharm.2022.122021. Epub 2022 Jul 13. Int J Pharm. 2022. PMID: 35842082

7

Implementable assay for monitoring minimum residual disease after radical treatment for colorectal cancer.

Nakano T, Takao S, Dairaku K, Uno N, Low SA, Hashimoto M, Tsuda Y, Hisamatsu Y, Toshima T, Yonemura Y, Masuda T, Eto K, Ikegami T, Fukunaga Y, Niida A, Nagayama S, Mimori K. Nakano T, et al. Among authors: uno n. Cancer Sci. 2024 Mar 26. doi: 10.1111/cas.16149. Online ahead of print. Cancer Sci. 2024. PMID: 38531808 Free article.

8

Rapid human genomic DNA cloning into mouse artificial chromosome via direct chromosome transfer from human iPSC and CRISPR/Cas9-mediated translocation.

Miyamoto H, Kobayashi H, Kishima N, Yamazaki K, Hamamichi S, Uno N, Abe S, Hiramuki Y, Kazuki K, Tomizuka K, Kazuki Y. Miyamoto H, et al. Among authors: uno n. Nucleic Acids Res. 2024 Feb 9;52(3):1498-1511. doi: 10.1093/nar/gkad1218. Nucleic Acids Res. 2024. PMID: 38180813 Free PMC article.

9

Treatment of CHO cells with Taxol and reversine improves micronucleation and microcell-mediated chromosome transfer efficiency.

Uno N, Satofuka H, Miyamoto H, Honma K, Suzuki T, Yamazaki K, Ito R, Moriwaki T, Hamamichi S, Tomizuka K, Oshimura M, Kazuki Y. Uno N, et al. Mol Ther Nucleic Acids. 2023 Jul 15;33:391-403. doi: 10.1016/j.omtn.2023.07.002. eCollection 2023 Sep 12. Mol Ther Nucleic Acids. 2023. PMID: 37547291 Free PMC article.

10

CRISPR gel: A one-pot biosensing platform for rapid and sensitive detection of HIV viral RNA.

Uno N, Li Z, Avery L, Sfeir MM, Liu C. Uno N, et al. Anal Chim Acta. 2023 Jun 29;1262:341258. doi: 10.1016/j.aca.2023.341258. Epub 2023 Apr 24. Anal Chim Acta. 2023. PMID: 37179057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page